Therapy Areas: Autoimmune
Bristol Myers Squibb to acquire Orbital Therapeutics for USD1.5bn to expand cell therapy portfolio
10 October 2025 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced on Friday that it has entered into a definitive agreement to acquire Orbital Therapeutics, a privately held biotec...
Celltrion launches AVTOZMA IV in the United States following FDA approval
2 October 2025 - South Korea-based Celltrion, Inc., a global biopharmaceutical company, announced on Thursday that it has launched AVTOZMA (CT-P47, tocilizumab-anoh) intravenous formulation in the Uni...
OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University
26 September 2025 - French biotechnology company OSE Immunotherapeutics SA (Euronext Paris:OSE) announced on Friday that it has agreed a strategic partnership with Inserm Transfert (on behalf of Inser...
Dr Eric Berg Joins Forces with Robert F. Kennedy Jr. to Advocate for Transparency in Vaccine Science and Public Health
25 September 2025 - Dr Eric Berg, D.C., an established health educator and best-selling author, has publicly aligned with Robert F. Kennedy Jr. in a call for greater transparency and integrity in vacc...
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
22 September 2025 - Medical technology company Shoulder Innovations Inc (NYSE: SI) on Monday announced the full commercial launch of the InSet 70 Humeral Stem, expanding its I-Series humeral stem prod...
EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi
22 September 2025 - Biotech company Alvotech S.A. (NASDAQ:ALVO) and Advanz Pharma, a UK-based pharmaceutical company with a focus on specialty, hospital and rare disease medicines, announced on Monday...